Archive | May, 2009

Study Suggests Higher Risk of Alzheimer Disease in Atrial Fibrillation Patients

Several former studies have demonstrated the association of vascular cognitive impairment risk factors such as diabetes, hypertension, stroke, and atherosclerosis with the impairment of cognitive functions. However, the link between heart rhythm disorder and Alzheimer disease (AD) has not been clearly defined. Now, a study presented at the annual scientific sessions of the Heart Rhythm Society, held during May 13-16, 2009, at Boston, reports an enhanced risk of developing Alzheimer disease in patients suffering from atrial fibrillation. Continue Reading

Posted in After 60, Basic Sciences, Cardiology, Emergency Medicine, Geriatrics, Mental Health, Neurology, Patient Care, Psychiatry0 Comments

De novo Cancers Following Organ Transplantation Have Adverse Outcomes

Several studies suggest that transplant recipients possess a high risk of developing cancer; however, the outcomes of de novo cancer in this population of patients have not been clearly defined. Now, researchers from the University of Cincinnati report the adverse outcomes of new cancers arising in transplant recipients compared to that of the general population, in the recent issue of the journal, Transplantation. Continue Reading

Posted in Basic Sciences, HIV / AIDS, Immunology, Medicine, Oncology, Transplant0 Comments

Urinary Exosomes Serve as Emerging Putative Biomarkers for Aggressive Prostate Cancer

Non-invasive tests, such as prostate specific antigen (PSA) estimation and digital rectal examination, are currently available for the detection of prostate cancer. However, the determination of the aggressiveness of the cancer for immediate treatment and surgery is a major challenge for medical professionals. Now, a study published in the recent issue of the British Journal of Cancer shows that the RNA present in the urinary exosomes (fatty capsules) of cancer patients act as effective biomarkers for predicting the aggressiveness of prostate cancer. Continue Reading

Posted in Basic Sciences, Biotechnology, Genomics, Lab Medicine, Molecular Biology, Oncology0 Comments

Stem Cell Therapy Shows Promise in Treating Stress Urinary Incontinence

Urinary incontinence, a condition characterized by the involuntary loss of urine, is estimated to impair the quality of life of more than 13 million women and around 5 million men, in the US alone. A recent randomized, blinded, multi-dose study reports that autologous muscle-derived cell (AMDC) transplantation into the bladder is safe in wide dosage ranges and effective in relieving the symptoms of stress urinary incontinence (SUI). The study results were presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA), held at Chicago. Continue Reading

Posted in Basic Sciences, Medicine, Regenerative Medicine, Stem Cells, Transplant, Urology0 Comments

Study Confirms Autoimmunity of Narcolepsy

The sleep disorder, narcolepsy has been found to arise due to the lack of the hormone hypocretin, which promotes wakefulness. Earlier, researchers have proposed that the hypocretin-producing cells might get selectively destroyed in individuals with one or more human leukocyte antigen (HLA) DQB1*0602 alleles. Now, the findings of a recent study published online in Nature Genetics, confirms the long-harbored suspicion that narcolepsy is an autoimmune disorder. This is touted to be the first documentation of the genetic association of T-cell receptor alpha (TRA@) locus that encodes the major HLA-peptide receptor, with any autoimmune disease. Continue Reading

Posted in Basic Sciences, Genetics, Genomics, Immunology, Mental Health, Microbiology, Molecular Biology, Neurology0 Comments

FDA Approves Iloperidone Against Acute Schizophrenia

Iloperidone (Fanaptâ„¢ | Vanda Pharmaceuticals Inc.), an atypical antipsychotic drug, received the U.S. Food and Drug Administration (FDA) approval for the acute treatment of schizophrenia in adults. The approval is based on safety data from over 3,000 patients and the results of two placebo-controlled short-term clinical studies, demonstrating the efficacy of iloperidone in reducing the symptoms of schizophrenia. Continue Reading

Posted in Basic Sciences, Clinical Research, Drug Development, Internal Medicine, Medicine, Mental Health, Neurology, Pharma, Pharma Industry, Psychiatry, Psychology0 Comments

Study Finds Novel Glycolysis Inhibitor that Slows Neuroblastoma Growth by 75%

The dependence of various cancer cells on the glycolytic pathway for their energy requirements has also been correlated with the aggressiveness of different types of tumors. Now, a recent study has found a novel glycolysis inhibitor, 3-BrOP that lowers the growth of neuroblastoma by 75% in xenograft models. The results of the study have been presented at the 22nd annual meeting of the American Society of Pediatric Hematology/Oncology held at San Diego, California, during April 22-25, 2009. Continue Reading

Posted in Basic Sciences, Chemotherapeutics, Clinical Research, Fetal Medicine, Internal Medicine, Medicine, Mental Health, Neurology, Oncology, Pediatrics, Pharma0 Comments

H1N1 Influenza Outbreak: Current Status and Prevention Guidelines

The recent outbreak of a new strain of the influenza A virus (H1N1) has been causing major havoc across the world, with various public health organizations taking aggressive steps to contain the disease. The World Health Organization (WHO) has raised the alert level for H1N1, earlier referred to as ‘Swine Flu’, to phase 5 on the six-point scale, which confirms human to human spread of the disease, and also indicates the increased chances for a flu pandemic. The WHO has currently reported 4,694 laboratory confirmed cases of the H1N1 influenza virus across 30 countries. Continue Reading

Posted in Basic Sciences, Biotechnology, Consumer Health, Critical Care, Featured, Genetics, Genomics, Immunology, Infectious Diseases, Internal Medicine, Lab Medicine, Medicine, Microbiology, Pathology, Patient Care, Pulmonology, Virology0 Comments

Researchers Induce Pluripotency in Human Blood Cells

The ethical and moral issues associated with the use of human embryonic stem (HESC) cells for treatment of diseases, have contributed to extensive research in the reprogramming of human somatic cells into induced pluripotent stem cells (iPS cells). Now, a team of US researchers has zeroed in an effective way to transform human blood cells into iPS cells, which could provide a readily accessible source for generating stem cells and also a potential alternative to embryonic stem cells. The study results were pre-published online in the March issue of the journal Blood. Continue Reading

Posted in Basic Sciences, Biotechnology, Biotherapeutics, Genetic Engineering, Genetics, Genomics, Medical Technology, Medicine, Stem Cells, Transplant0 Comments

Transcatheter Aortic Valve Implantation on the Beating Heart Improves Clinical Outcome in Aortic Stenosis

Aortic stenosis (AS), a valvular heart disease, is most commonly treated by aortic valve replacement (AVR) surgery in severe symptomatic cases. However, the conventional surgery is contraindicated in patients of advanced age, and with comorbidities and extensive ascending aorta calcification. Now, a recent study published in the journal, Deutsches Ärzteblatt International demonstrated clinical improvements in AS patients at a high risk for open surgery, with a safer and less invasive catheter-based aortic valve implantation. Continue Reading

Posted in Cardiology, Critical Care, Medical Devices, Medical Technology0 Comments

Advert

Upcoming Events

Stay Updated Via Our Twitter Alerts

Follow mndalerts on Twitter

Categories

Archives